R. Schreiber | Maastricht University

van Veggel, L., Schepers, M., Tiane, A., Kumar, V., Willems, E., Rombaut, B., Noordijk, J., Vangansewinkel, T., Li, A., Wolfs, E., Ozcan, B., Nouboers, E., Moya, P. R., Sauer, D. B., Diliën, H., Hellings, N., Schreiber, R., & Vanmierlo, T. (2025). EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis. Biomedicine & Pharmacotherapy, 186, 117960. Article 117960. https://doi.org/10.1016/j.biopha.2025.117960

Meer informative over deze publicatie

Magaraggia, I., Krauskopf, J., Ramaekers, J. G., You, Y., de Nijs, L., Briedé, J. J., & Schreiber, R. (2025). Harnessing brain-derived extracellular vesicles to support RDoC-based drug development. Neuroscience Applied, 4, Article 105406. https://doi.org/10.1016/j.nsa.2024.105406

Meer informative over deze publicatie

van Veggel, L., Voets, A. M., Vanmierlo, T., & Schreiber, R. (2024). Insights from an academic endeavor into central nervous system drug discovery. Neural Regeneration Research, 20(6), 1717-1718. https://doi.org/10.4103/NRR.NRR-D-24-00340

Meer informative over deze publicatie

Schreiber, R. (2024). Preface to the First Edition. In Modern CNS Drug Discovery: : Novel Therapeutics for Psychiatric and Neurological Diseases: from Target Identification to Regulatory Approval (2 ed., pp. viii-x). Springer.

Meer informative over deze publicatie

Schreiber, R. (2024). Preface to the Second Edition. In R. Schreiber (Ed.), Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases: from Target Identification to Regulatory Approval (2 ed., pp. v-vii). Springer.

Meer informative over deze publicatie

Schreiber, R. (2024). Connecting the Dots in Translational Neuroscience. In R. Schreiber (Ed.), Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases: from Target Identification to Regulatory Approval (2 ed., pp. 209-213). Springer. https://doi.org/10.1007/978-3-031-61992-2_11

Meer informative over deze publicatie

Broy, J., Schreiber, R., & Govers, M. (2024). From Scientists to Innovators for Industry: An European Program Addressing the Workforce Challenge in the Pharma Industry. In R. S. (Ed.), Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases: from Target Identification to Regulatory Approval (2 ed., pp. 31-48). Springer. https://doi.org/10.1007/978-3-031-61992-2_3

Meer informative over deze publicatie

Schreiber, R., Govers, M., & Van der Lugt, A. (2024). Innovator, Entrepreneur, Leader: The Tripartite Drug Discovery Neuroscientist. In R. S. (Ed.), Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases: from Target Identification to Regulatory Approval (2 ed., pp. 9-29). Springer. https://doi.org/10.1007/978-3-031-61992-2_2

Meer informative over deze publicatie

Blasco, G., Schreiber, R., & Van Kruining, D. (2024). Mass Spectrometry-Based Methods in CNS Drug Discovery. In R. S. (Ed.), Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases: from Target Identification to Regulatory Approval (2 ed., pp. 87-115). Springer. https://doi.org/10.1007/978-3-031-61992-2_6

Meer informative over deze publicatie

Schreiber, R. (2024). Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases. (2 ed.) Springer. https://doi.org/10.1007/978-3-031-61992-2

Meer informative over deze publicatie